ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder—the influence of impulsivity as a mediating factor-Reference-Cited by-同舟云学术

ADHD: prevalence and effect on opioid use disorder treatment outcome in a French sample of patients receiving medication for opioid use disorder—the influence of impulsivity as a mediating factor

Published:2024-09-09 Issue:1 Volume:21 Page:
ISSN:1477-7517
Container-title:Harm Reduction Journal
language:en
Short-container-title:Harm Reduct J

Author:

Beslot Auxane,Grall-Bronnec Marie,Balem Marianne,Schreck Benoit,Laforgue Edouard-Jules,Victorri-Vigneau Caroline,Guillou-Landreat Morgane,Leboucher Juliette, ,Bodenez Pierre,Grall-Bronnec Marie,Guillou-Landréat Morgane,Le Geay Bertrand,Martineau Isabelle,Levassor Philippe,Bolo Paul,Guillet Jean-Yves,Guillery Xavier,Dano Corine,Challet-Bouju Gaëlle,Cabelguen Clémence

Funder

French Inter-ministerial Mission for Combating Drugs and Addictive Behaviours (MILDECA) and Université Paris 13

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12954-024-01079-7.pdf

Reference83 articles.

1. Kolodny A, Courtwright DT, Hwang CS, Kreiner P, Eadie JL, Clark TW, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559–74.

2. Clark RE, Baxter JD, Aweh G, O’Connell E, Fisher WH, Barton BA. Risk factors for Relapse and higher costs among Medicaid members with opioid dependence or abuse: opioid agonists, comorbidities, and treatment history. J Subst Abuse Treat. 2015;57:75–80.

3. Hser YI, Evans E, Grella C, Ling W, Anglin D. Long-term course of opioid addiction. Harv Rev Psychiatry. 2015;23(2):76–89.

4. Grall-Bronnec M, Laforgue EJ, Challet-Bouju G, Cholet J, Hardouin JB, Leboucher J, et al. Prevalence of coaddictions and rate of successful treatment among a French sample of opioid-dependent patients with Long-Term Opioid Substitution Therapy: the OPAL Study. Front Psychiatry. 2019;10:726.

5. Ross S, Peselow E. Co-occurring psychotic and addictive disorders: Neurobiology and diagnosis. Clin Neuropharmacol. 2012;35(5):235–43.